Evidence map›Paper›PMID 27566676›Full record

ArticleJournal of cardiovascular electrophysiology2016

Strategies for Risk Analysis and Disease Classification in Atrial Fibrillation.

Sara Adelman, Georges Daoud, Peter J Mohler

Erratum issuedAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sara AdelmanDepartments of Physiology and Cell Biology, Internal and Medicine, Dorothy M. Davis Heart and Lung Research Institute, Columbus, Ohio, USA.
Georges DaoudDepartments of Physiology and Cell Biology, Internal and Medicine, Dorothy M. Davis Heart and Lung Research Institute, Columbus, Ohio, USA.
Peter J MohlerDepartments of Physiology and Cell Biology, Internal and Medicine, Dorothy M. Davis Heart and Lung Research Institute, Columbus, Ohio, USA.

Funding

Defining novel mechanisms for human arrhythmiaR35HL135754 · NHLBI · OHIO STATE UNIVERSITY · PI MOHLER, PETER J. · 2017 to 2023
$6.0M
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitabilityR01HL083422 · NHLBI · VANDERBILT UNIVERSITY · PI MOHLER, PETER J. · 2006 to 2016
$3.8M
Role of ankyrin-B in human arrhythmiaR01HL084583 · NHLBI · UNIVERSITY OF IOWA · PI MOHLER, PETER J. · 2006 to 2015
$3.4M
Defining novel mechanisms for regulation of atrial INa and arrhythmiasR01HL134824 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY, MOHLER, PETER J. · 2017 to 2020
$3.0M
EHD proteins in cardiac membrane protein targeting and remodelingR01HL114383 · NHLBI · OHIO STATE UNIVERSITY · PI BOYDEN, PENELOPE ALTMAN, MOHLER, PETER J. · 2013 to 2016
$2.1M
American Heart AssociationNational Institutes of Health HL084583, HL083422, HL114383NHLBI NIH HHS R01 HL083422NHLBI NIH HHS R01 HL084583NHLBI NIH HHS R01 HL114383NHLBI NIH HHS R01 HL134824NHLBI NIH HHS R35 HL135754Philip and Sheryl Heit Fund for Cardiovascular ResearchWilliam D. and Jacquelyn L. Wells Fund for Cardiovascular Research
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atrial fibrillationfibrosisgeneticsinflammation

Identifiers

PMID27566676
PMCPMC5326704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.